- Report
- June 2025
- 77 Pages
Global
From €5237EUR$5,850USD£4,461GBP
- Report
- June 2025
- 381 Pages
Global
From €5237EUR$5,850USD£4,461GBP
- Report
- June 2025
- 490 Pages
Global
From €5237EUR$5,850USD£4,461GBP
- Report
- June 2025
- 72 Pages
Global
From €5237EUR$5,850USD£4,461GBP
- Report
- June 2025
- 72 Pages
Global
From €5237EUR$5,850USD£4,461GBP
- Report
- June 2025
- 176 Pages
Global
From €5237EUR$5,850USD£4,461GBP
- Report
- June 2025
- 393 Pages
Global
From €5237EUR$5,850USD£4,461GBP
- Report
- June 2025
- 399 Pages
Global
From €5237EUR$5,850USD£4,461GBP
- Report
- June 2025
- 84 Pages
Global
From €5237EUR$5,850USD£4,461GBP
- Report
- June 2025
- 285 Pages
Global
From €5237EUR$5,850USD£4,461GBP
- Report
- June 2025
- 78 Pages
Global
From €5237EUR$5,850USD£4,461GBP
- Report
- June 2025
- 385 Pages
Global
From €5237EUR$5,850USD£4,461GBP
- Report
- June 2025
- 144 Pages
Global
From €5237EUR$5,850USD£4,461GBP
- Report
- June 2025
- 62 Pages
Global
From €5237EUR$5,850USD£4,461GBP
- Report
- June 2025
- 290 Pages
Global
From €5237EUR$5,850USD£4,461GBP
- Report
- June 2025
- 396 Pages
Global
From €5237EUR$5,850USD£4,461GBP
- Report
- June 2025
- 282 Pages
Global
From €5237EUR$5,850USD£4,461GBP
- Report
- June 2025
- 487 Pages
Global
From €5237EUR$5,850USD£4,461GBP
- Report
- June 2025
- 383 Pages
Global
From €5237EUR$5,850USD£4,461GBP
- Report
- June 2025
- 379 Pages
Global
From €5237EUR$5,850USD£4,461GBP

The Contract Research Organization (CRO) market within the biotechnology sector is a rapidly growing industry. It provides services to biotechnology companies, such as drug discovery, preclinical and clinical trials, and regulatory affairs. CROs are often used to outsource research and development activities, allowing biotechnology companies to focus on their core competencies. CROs also provide access to specialized expertise and resources, such as specialized laboratory equipment and personnel.
CROs are increasingly being used to reduce costs and speed up the development process. They are also used to reduce the risk associated with drug development, as they can provide access to a wide range of expertise and resources.
Some of the major companies in the CRO market include Parexel, Quintiles, Charles River Laboratories, Covance, and PRA Health Sciences. Show Less Read more